Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 2020; published online Dec 8. http://dx.doi.org/10.1016/S0140-6736(20)32661-1. P16 -21 Table S6 Serious adverse events by MedDRA system organ class and preferred term at any time during the study, in randomised participants who received at least one dose of vaccine.   Lots of Nasty adverse events in th
    • Like
    1